If $BCRX Galidesivir Apri Randamozied trial shows encouraging wondering:
Since Remdesivir &amp; Galidesivir are similar and Galidesivir maybe able to be administered orally and has mass production capacity, $BCRX an acquisition candidate? $GILD $PFE?
A purely speculative thought????